SCHEMBL21552385

SCHEMBL21552385

O=C1COc2cc(I)c(Br)cc2N1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.49
PARP1 P09874 3/20 0.45
ALDH1A1 P00352 4/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 4/20 0.41
PDE3B Q13370 3/20 0.41
PDE3A Q14432 3/20 0.41
TP53 P04637 2/20 0.41
THRB P10828 1/20 0.41
PKM P14618 2/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
NR3C2 P08235 2/20 0.39
GAA P10253 2/20 0.39
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2955843 0.86 MMP12 (0.54) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL18152757 0.80 MMP12 (0.49) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL24286262 0.80 MMP12 (0.49) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL305188 0.80 MMP12 (0.57) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL8192799 0.80 NR3C2 (0.51) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL18264334 0.77 MMP12 (0.49) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL7670635 0.77 MMP12 (0.49) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL3342717 0.77 MMP12 (0.49) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL1853066 0.77 MMP12 (0.57) MMP12PARP1ALDH1A1KMT2AMAPT
SCHEMBL5914785 0.77 NR3C2 (0.51) MMP12PARP1ALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3790551-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2021-03-17 EP disclosed
WO-2019217307-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2019-11-14 WO disclosed
WO-2019217307-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2019-11-14 WO disclosed